disulfiram has been researched along with Kahler Disease in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disulfiram (DSF) is an FDA approved anti-alcoholism drug in use for more than 60 years." | 1.56 | Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways. ( Dai, Y; Feng, X; Jiang, W; Jiang, Y; Liu, X; Ni, Y; Wang, Y; Xing, X; Xu, Y; Zheng, C; Zhou, Q, 2020) |
| "Disulfiram (DSF) is an aldehyde dehydrogenase inhibitor currently used for the treatment of alcoholism." | 1.38 | Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies. ( Adamo, L; Amato, G; Anastasi, G; Buccheri, S; Cavalli, M; Chiarenza, A; Conticello, C; De Maria, R; Di Raimondo, F; Giuffrida, R; Giustolisi, R; Gulisano, M; Lombardo, L; Martinetti, D; Parrinello, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, Y | 1 |
| Sasano, T | 1 |
| Arima, Y | 1 |
| Kushima, S | 1 |
| Tsujita, K | 1 |
| Matsuoka, M | 1 |
| Hata, H | 1 |
| Chroma, K | 1 |
| Skrott, Z | 1 |
| Gursky, J | 1 |
| Bacovsky, J | 1 |
| Moudry, P | 1 |
| Buchtova, T | 1 |
| Mistrik, M | 1 |
| Bartek, J | 1 |
| Xu, Y | 1 |
| Zhou, Q | 1 |
| Feng, X | 1 |
| Dai, Y | 1 |
| Jiang, Y | 1 |
| Jiang, W | 1 |
| Liu, X | 1 |
| Xing, X | 1 |
| Wang, Y | 1 |
| Ni, Y | 1 |
| Zheng, C | 1 |
| Weiser Drozdkova, D | 1 |
| Smesny Trtkova, K | 1 |
| Salem, K | 1 |
| McCormick, ML | 1 |
| Wendlandt, E | 1 |
| Zhan, F | 1 |
| Goel, A | 1 |
| Conticello, C | 1 |
| Martinetti, D | 1 |
| Adamo, L | 1 |
| Buccheri, S | 1 |
| Giuffrida, R | 1 |
| Parrinello, N | 1 |
| Lombardo, L | 1 |
| Anastasi, G | 1 |
| Amato, G | 1 |
| Cavalli, M | 1 |
| Chiarenza, A | 1 |
| De Maria, R | 1 |
| Giustolisi, R | 1 |
| Gulisano, M | 1 |
| Di Raimondo, F | 1 |
| Hannan, GN | 1 |
| Underwood, PA | 1 |
| McAuslan, BR | 1 |
1 review available for disulfiram and Kahler Disease
| Article | Year |
|---|---|
Possible Therapeutic Potential of Disulfiram for Multiple Myeloma.
Topics: Cell Line, Tumor; Copper; Disulfiram; Humans; Multiple Myeloma; Neoplasm Recurrence, Local | 2021 |
6 other studies available for disulfiram and Kahler Disease
| Article | Year |
|---|---|
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bortezomib; Cell L | 2022 |
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment.
Topics: Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Disulfiram; Drug Repositioning; Drug Resistance | 2022 |
Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; | 2020 |
Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.
Topics: Adult; Apoptosis; Bortezomib; Cell Line, Tumor; Disease-Free Survival; Disulfiram; Drug Resistance, | 2015 |
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Copper; Disulfiram; En | 2012 |
Regulation of polypeptide synthesis in endothelial cells and hybridoma cells by the copper ionophore disulfiram.
Topics: Animals; Antibody Formation; Cattle; Cells, Cultured; Collagen; Disulfiram; Endothelium; Fibronectin | 1982 |